Q Global Advisors’s CERo Therapeutics Warrants CEROW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-170,785
| Closed | -$2K | – | 51 |
|
|
2025
Q3 | $2K | Hold |
170,785
| – | – | ﹤0.01% | 40 |
|
|
2025
Q2 | $4K | Hold |
170,785
| – | – | ﹤0.01% | 43 |
|
|
2025
Q1 | $2K | Hold |
170,785
| – | – | ﹤0.01% | 49 |
|
|
2024
Q4 | $1K | Hold |
170,785
| – | – | ﹤0.01% | 50 |
|
|
2024
Q3 | $1K | Hold |
170,785
| – | – | ﹤0.01% | 65 |
|
|
2024
Q2 | $3K | Hold |
170,785
| – | – | ﹤0.01% | 75 |
|
|
2024
Q1 | $12K | Hold |
170,785
| – | – | ﹤0.01% | 65 |
|
|
2023
Q4 | $4K | Hold |
170,785
| – | – | ﹤0.01% | 74 |
|
|
2023
Q3 | $12K | Hold |
170,785
| – | – | 0.01% | 57 |
|
|
2023
Q2 | $10K | Hold |
170,785
| – | – | 0.01% | 83 |
|
|
2023
Q1 | $7K | Hold |
170,785
| – | – | ﹤0.01% | 126 |
|
|
2022
Q4 | $7K | Hold |
170,785
| – | – | ﹤0.01% | 90 |
|
|
2022
Q3 | $12K | Hold |
170,785
| – | – | 0.01% | 62 |
|
|
2022
Q2 | $17K | Hold |
170,785
| – | – | 0.01% | 152 |
|
|
2022
Q1 | $37K | Buy |
170,785
+70,785
| +71% | +$26.3K | 0.02% | 156 |
|
|
2021
Q4 | $42K | Buy |
+100,000
| New | +$46.1K | 0.01% | 215 |
|
Other funds holding CEROW
Q Global Advisors's CEROW Position: Q4 2025 in Review
Q Global Advisors sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 170,785 shares — an estimated $2K sold.
Q Global Advisors first reported a position in CEROW in Q4 2021 and held it in 16 quarters. The position peaked at $42K in Q4 2021. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.
- Q Global Advisors reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
- Q Global Advisors sold 170,785 CERo Therapeutics Warrants shares in Q4 2025, an estimated $2K.
- Q Global Advisors first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 16 quarters.
- Q Global Advisors's CERo Therapeutics Warrants position peaked at $42K in Q4 2021.
- 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.
Based on Q Global Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.